Zevra Therapeutics ZVRA SEC Filings

NASDAQ ZVRA
$12.48 -0.06 (-0.48%)
As of: Sep 4, 2026 · 2:32 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Zevra Therapeutics, Inc. (ZVRA) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index